🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase 1, open-label study to assess the PK, safety and tolerabili...
Status
Completed
Location
Division of Clinical Pharmacology (DCP), University of Miami
Start Date
2021-02-25
Trial ID
NCT04787562
This is a Phase 1, open-label, single-center study of XNW4107 and imipenem/...
Status
Completed
Location
Pulmonary Associates PA
Start Date
2021-03-25
Trial ID
NCT04802863
Treatments Being Tested
This is a Phase 1, randomized, double-blind, placebo-controlled study to as...
Status
Completed
Location
Orlando Clinical Research Center (OCRC)
Start Date
2021-03-02
Trial ID
NCT04801043
Treatments Being Tested
This is a 3-part, first-in-human study to evaluate the safety, tolerability...
Status
Completed
Location
Pharmaron CPC
Start Date
2020-07-10
Trial ID
NCT04482569
Treatments Being Tested
This is A Multicenter, Randomized, Double-Blind, Double-Dummy, Comparative,...
Status
Unknown
Location
University of Maryland Medical Center
Start Date
2023-03-30
Trial ID
NCT05204368
Treatments Being Tested
This study aims to compare treatment with Imipenem/Cilastatin-XNW4107 (IMI-...
Status
Completed
Location
Denver Health and Hospital Authority
Start Date
2022-07-31
Trial ID
NCT05204563
Treatments Being Tested